ARCHIVES

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

This article is from The Cancer Letter archive.

Vol. 18 No. 29 | July 17, 1992

Download PDF Visit The Full Archive

Related Articles

Study Section Members Likelier to Be Funded

August 1, 1986

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

In Brief: Ireland Cancer Center Named Comprehensive; UPCI Appoints Four Program Directors

February 27, 1998

Don’t Blame FDA For All Problems, Broder Says

September 7, 1990

Gardasil Approved To Prevent Vulvar And Vaginal Cancers

September 26, 2008

UT Southwestern, M.D. Anderson Form Cancer Center In Dallas

May 5, 1995